These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 12384979
1. K vitamins, PTP antagonism, and cell growth arrest. Carr BI, Wang Z, Kar S. J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979 [Abstract] [Full Text] [Related]
2. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin. Wang Z, Wang M, Carr BI. J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308 [Abstract] [Full Text] [Related]
3. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. Osada S, Osada K, Carr BI. J Mol Biol; 2001 Dec 07; 314(4):765-72. PubMed ID: 11733995 [Abstract] [Full Text] [Related]
5. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound. Kar S, Wang M, Rosi KS, Wilcox CS, Carr BI. Carcinogenesis; 2004 Dec 07; 25(12):2345-51. PubMed ID: 15319298 [Abstract] [Full Text] [Related]
6. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs. Wang Z, Southwick EC, Wang M, Kar S, Rosi KS, Wilcox CS, Lazo JS, Carr BI. Cancer Res; 2001 Oct 01; 61(19):7211-6. PubMed ID: 11585757 [Abstract] [Full Text] [Related]
8. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Kar S, Wang M, Ham SW, Carr BI. Biochem Pharmacol; 2006 Nov 15; 72(10):1217-27. PubMed ID: 16930563 [Abstract] [Full Text] [Related]
9. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog. Kar S, Adachi T, Carr BI. J Cell Physiol; 2002 Mar 15; 190(3):356-64. PubMed ID: 11857451 [Abstract] [Full Text] [Related]
10. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway. Wang Z, Wang M, Carr BI. J Cell Physiol; 2005 Jun 15; 203(3):510-9. PubMed ID: 15534860 [Abstract] [Full Text] [Related]
11. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Wang Z, Ge L, Wang M, Carr BI. J Cell Physiol; 2006 Jul 15; 208(1):133-40. PubMed ID: 16596619 [Abstract] [Full Text] [Related]
12. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. Osada S, Saji S, Osada K. Cancer; 2001 Mar 15; 91(6):1156-65. PubMed ID: 11267961 [Abstract] [Full Text] [Related]
13. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues. Kar S, Lefterov IM, Wang M, Lazo JS, Scott CN, Wilcox CS, Carr BI. Biochemistry; 2003 Sep 09; 42(35):10490-7. PubMed ID: 12950176 [Abstract] [Full Text] [Related]
16. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Kar S, Wang M, Carr BI. Cancer Chemother Pharmacol; 2008 Oct 09; 62(5):831-40. PubMed ID: 18246350 [Abstract] [Full Text] [Related]
17. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT. Anticancer Res; 2002 Oct 09; 22(3):1615-27. PubMed ID: 12168845 [Abstract] [Full Text] [Related]
19. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells. Mizuno R, Oya M, Hara S, Matsumoto M, Horiguchi A, Ohigashi T, Marumo K, Murai M. Oncol Rep; 2005 Sep 09; 14(3):639-44. PubMed ID: 16077967 [Abstract] [Full Text] [Related]